Pharming Group NV (PHGUF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,684 | -16,624 | -12,012 | -9,981 | -13,288 |
| Depreciation Amortization | 5,628 | 5,921 | 15,925 | 8,370 | 5,468 |
| Accounts receivable | -4,963 | 7,461 | -18,539 | -12,902 | -5,539 |
| Accounts payable and accrued liabilities | -2,255 | -9,414 | 16,228 | 8,075 | 4,833 |
| Other Working Capital | -10,333 | -1,048 | -16,961 | -15,577 | -11,013 |
| Other Operating Activity | 7,739 | 6,057 | -1,943 | -6,864 | -12,867 |
| Operating Cash Flow | $-20,868 | $-7,647 | $-17,302 | $-28,879 | $-32,406 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -294 | -80 | 19,842 | 19,947 | 20,094 |
| Purchase Of Investment | -112,453 | -94,778 | -382,014 | -231,901 | -87,347 |
| Sale Of Investment | 149,805 | 95,522 | 232,811 | 86,451 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -27 | 23 | N/A |
| Other Investing Activity | 0 | 0 | -27 | 23 | 0 |
| Investing Cash Flow | $37,058 | $664 | $-129,388 | $-125,480 | $-67,253 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 104,802 | N/A | N/A | N/A | N/A |
| Debt Repayment | -134,922 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -655 | -2,471 | -1,039 | -19 | -5,259 |
| Financing Cash Flow | $-30,775 | $-2,471 | $-1,039 | $-19 | $-5,259 |
| Exchange Rate Effect | -14 | -395 | 2,128 | 1,689 | 2,601 |
| Beginning Cash Position | 61,741 | 61,741 | 207,342 | 207,342 | 207,342 |
| End Cash Position | 47,142 | 51,892 | 61,741 | 54,653 | 105,026 |
| Net Cash Flow | $-14,599 | $-9,849 | $-145,601 | $-152,689 | $-102,316 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,868 | -7,647 | -17,302 | -28,879 | -32,406 |
| Capital Expenditure | -294 | -80 | -1,437 | -1,133 | -986 |
| Free Cash Flow | -21,162 | -7,727 | -18,739 | -30,012 | -33,392 |